Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
McKinsey
AstraZeneca
Queensland Health
Baxter
Colorcon
Johnson and Johnson
Merck
Harvard Business School
Moodys

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019786

« Back to Dashboard

NDA 019786 describes LOPRESSOR, which is a drug marketed by Novartis and Us Pharms Holdings I and is included in four NDAs. It is available from three suppliers. Additional details are available on the LOPRESSOR profile page.

The generic ingredient in LOPRESSOR is hydrochlorothiazide; metoprolol tartrate. There are thirty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
Summary for 019786
Tradename:LOPRESSOR
Applicant:Novartis
Ingredient:metoprolol fumarate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 100MG TARTRATE
Approval Date:Dec 27, 1989TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 200MG TARTRATE
Approval Date:Dec 27, 1989TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 300MG TARTRATE
Approval Date:Dec 27, 1989TE:RLD:No

Expired US Patents for NDA 019786

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LOPRESSOR metoprolol fumarate TABLET, EXTENDED RELEASE;ORAL 019786-003 Dec 27, 1989 ➤ Subscribe ➤ Subscribe
Novartis LOPRESSOR metoprolol fumarate TABLET, EXTENDED RELEASE;ORAL 019786-004 Dec 27, 1989 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Cerilliant
Daiichi Sankyo
Novartis
Dow
Fish and Richardson
Queensland Health
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot